International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer


Recommended Conferences for Non Alcoholic Fatty Liver Disease

Non Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease

As per available reports about 8 relevant journals, 13 Conferences, 28 workshops are presently dedicated exclusively to Non-alcoholic fatty liver disease and about 64 articles are being published on breathing disorder.

Non-alcoholic fatty liver disease is a term used to describe the accumulation of fat in the liver of people who drink little or no alcohol. Non-alcoholic fatty liver disease is common and, for most people, causes no signs and symptoms and no complications. But in some people with non-alcoholic fatty liver disease, the fat that accumulates can cause inflammation and scarring in the liver. This more serious form of non-alcoholic fatty liver disease is sometimes called non-alcoholic steatohepatitis. 3rd World Congress on Hepatitis and Liver Diseases consist of following tracks Hepatitis : Care and CureHBV : From Discovery to Cure, Latest advances in the treatment of HCV, Hepatitis Vaccination, Advance Technologies for the Diagnosis and Treatment of Liver Diseases

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

Non-alcoholic liver {disease} disease (NAFLD) is one reason behind a liver disease, occurring once fat is deposited (steatosis) within the liver undue to excessive alcohol use. Advancement of NASH may be the consequence of 2 liver abuses. With the beginning affront, macrovesicular steatosis happens which an appearance of inordinate triglyceride is amassing in the liver. Insulin safety and resulting hyperinsulinemia seem to prompt changes in the hepatic pathways of uptake, union, debasement, and emission of free unsaturated fats and eventually to collection of lipids in the hepatocytes. These progressions appear to make the liver defenseless to a second affront, bringing about an incendiary reaction and movement of liver harm. Oxidative anxiety, fundamentally created by mitochondrial brokenness, and pro-inflammatory cytokines (TNF-alpha), are accepted to assume a vital part in the movement of liver harm in NAFLD. Potential oxidative stressors incorporate hepatic iron, leptin, cell reinforcement lacks, and intestinal microscopic organisms.

The liver is a large, meaty organ that sits on the right side of the belly. Weighing about 3 pounds, the liver is reddish-brown in colour and feels rubbery to the touch. Normally you can't feel the liver, because it's protected by the rib cage. The liver's main job is to filter the blood coming from the digestive tract, before passing it to the rest of the body. The liver also detoxifies chemicals and metabolizes drugs. As it does so, the liver secretes bile that ends up back in the intestines. The liver also makes proteins important for blood clotting and other functions. Liver conditions include Hepatitis, Cirrhosis, Liver cancer and Liver failure, Ascites, Gallstones and Hemochromatosis.

Market Analysis:

In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016. The global liver disease therapeutics market totalled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

International symposium and workshops

15th international symposium on viral hepatitis and liver disease June 26-28, 2015, Berlin Germany

6th International Symposium on Albumin Dialysis, August 28 – 30, 2015, Rostock-Warnemünde.

List of Best International Conferences:

  • 3rd Hepatitis and Liver Diseases Conference, October 17-19, 2016 Dubai, UAE
  • Hepatitis Vaccines Conference, June 16-18, 2016 Rome, Italy
  • 2nd Hepatology Conference, May 09-11, 2016 Chicago, Illinois, USA
  • Clinical Gastroenterology and Hepatology Conference, October 03-05, 2016 Toronto, Canada
  • 6th Conference on Coagulopathy of Liver Disease October 3rd and 4th 2015, Charlottesville, Virginia
  • 10th UVA Annual Conference of Liver Disease and Gastroenterology 2015, May 29 - 30, 2015, Charlottesville, Virginia United States Of America 
  • ICVH 2015: 17th International Conference on Viral Hepatitis London, United Kingdom September 25 - 26, 2015
  • 15th Symposium on Viral Hepatitis and Liver Disease June 26-28, 2015, berlin Germany
  • The Viral Hepatitis Congress 10–12 September 2015, Frankfurt am Main, Germany
  • 2nd Hepatitis Cure & Eradication Meeting November 11 – 12, 2015, Vancouver, BC
  • 4th Canadian Symposium on Hepatitis C Virus
  • TLTS 2015 — THE LIVER TRANSPLANT SYMPOSIUM 06 -08 Nov 2015 Singapore
  • 2nd Asian Conference on Hepatitis & HIV Conference 10th to 11th May 2013 Beijing, China
  • 4th ACHA - Asian Conference on Hepatitis and AIDS 22nd -23rd May 2015:XI’AN, CHINA

Relevant Society and Associations

  • American Liver Foundation
  • American Association for the Study of Liver Diseases
  • British Liver Trust
  • Canadian Liver Foundation
  • Asian Pacific Association for the Study of Liver (APASL)
  • The British Association for the Study of the Liver
  • The Hong Kong Association for the Study of the Liver Diseases
  • Children’s liver diseases foundation
  • Australian Liver Association
  • Korean Association for the Study of the Liver (KASL)
  • International liver cancer association
  • European Association for the Study of the Liver (EASL)
  • The Japanese Society of Hepatology (JSH)
  • Russian Scientific Liver Society (RSLS)
  • The Happy Liver Society
  • Canadian Society of Intestinal Research
  • The Hepatobiliary Cancers Foundation
  • Asia-Pacific Primary Liver Cancer Expert (APPLE)


  • Intrasense
  • Echosens
  • Gambro GmbH
  • Hepa Wash GmbH
  • Metabolic Solutions
  • Wagner Analysen Technik
  • Excorp Medical
  • OrganOx Limited
  • PULSION Medical Systems AG
  • Vital Therapies, Inc.
  • MDS Nordion
  • EMcision Limited
  • Conatus Pharmaceuticals Inc.

This page will be updated regularly.

This page was last updated on July 19, 2024

Conference Series Destinations